| Primary |
| Drug Use For Unknown Indication |
36.3% |
| Product Used For Unknown Indication |
21.8% |
| Hypertension |
17.8% |
| Cardiac Failure |
3.9% |
| Atrial Fibrillation |
3.9% |
| Cardiac Failure Chronic |
1.6% |
| Coronary Artery Disease |
1.4% |
| Blood Pressure |
1.3% |
| Myocardial Infarction |
1.3% |
| Myocardial Ischaemia |
1.3% |
| Cardiovascular Disorder |
1.2% |
| Pain |
1.2% |
| Essential Hypertension |
1.1% |
| Oedema |
1.0% |
| Acute Myocardial Infarction |
0.8% |
| Angina Pectoris |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Depression |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Arthritis |
0.7% |
|
| Syncope |
8.5% |
| Vertigo |
7.4% |
| Hypotension |
6.9% |
| Drug Interaction |
5.9% |
| Dyspnoea |
5.9% |
| Renal Failure |
5.9% |
| Tachycardia |
5.9% |
| Vomiting |
5.9% |
| Deafness Unilateral |
5.3% |
| Somnolence |
5.3% |
| Ventricular Tachycardia |
4.8% |
| Bradycardia |
4.3% |
| Malaise |
3.7% |
| Renal Failure Acute |
3.7% |
| Sinus Bradycardia |
3.7% |
| Suicidal Ideation |
3.7% |
| Toxic Skin Eruption |
3.7% |
| Bradyarrhythmia |
3.2% |
| Hepatitis |
3.2% |
| Nausea |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
31.4% |
| Hypertension |
23.9% |
| Drug Use For Unknown Indication |
9.0% |
| Atrial Fibrillation |
5.5% |
| Cardiac Failure |
4.8% |
| Type 2 Diabetes Mellitus |
4.2% |
| Myocardial Infarction |
2.4% |
| Myocardial Ischaemia |
2.3% |
| Pain |
2.1% |
| Coronary Artery Disease |
2.0% |
| Congestive Cardiomyopathy |
1.8% |
| Breast Cancer |
1.5% |
| Diabetes Mellitus |
1.3% |
| Hyperuricaemia |
1.2% |
| Ill-defined Disorder |
1.2% |
| Hypothyroidism |
1.1% |
| Prophylaxis |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Cardiovascular Disorder |
1.1% |
| Hypercholesterolaemia |
1.1% |
|
| Syncope |
11.0% |
| Renal Failure Acute |
8.3% |
| Ventricular Tachycardia |
6.5% |
| Fall |
6.3% |
| Vomiting |
6.1% |
| Interstitial Lung Disease |
5.9% |
| Hypotension |
5.6% |
| Bradycardia |
5.4% |
| Drug Interaction |
5.0% |
| Dyspnoea |
5.0% |
| Renal Failure |
4.3% |
| Neutropenia |
4.1% |
| Suicide Attempt |
3.8% |
| Loss Of Consciousness |
3.6% |
| Atrial Fibrillation |
3.4% |
| Somnolence |
3.4% |
| Thrombocytopenia |
3.4% |
| Condition Aggravated |
3.2% |
| Angioedema |
2.9% |
| Dizziness |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.1% |
| Hypertension |
18.8% |
| Drug Use For Unknown Indication |
14.1% |
| Rheumatoid Arthritis |
5.5% |
| Atrial Fibrillation |
5.1% |
| Prophylaxis |
3.7% |
| Diabetes Mellitus |
2.7% |
| Pain |
2.7% |
| Cardiac Failure |
2.7% |
| Type 2 Diabetes Mellitus |
2.6% |
| Coronary Artery Disease |
2.3% |
| Hypercholesterolaemia |
2.1% |
| Depression |
1.9% |
| Osteoporosis |
1.7% |
| Thrombosis Prophylaxis |
1.5% |
| Multiple Myeloma |
1.5% |
| Myocardial Ischaemia |
1.3% |
| Breast Cancer |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
| Hepatitis C |
1.2% |
|
| Renal Failure Acute |
10.7% |
| Vomiting |
10.5% |
| Renal Failure |
6.5% |
| Myocardial Infarction |
5.9% |
| Thrombocytopenia |
5.7% |
| Rhabdomyolysis |
5.6% |
| Pneumonia |
5.3% |
| Weight Decreased |
4.9% |
| Pyrexia |
4.3% |
| Death |
4.3% |
| Syncope |
4.2% |
| International Normalised Ratio Increased |
4.2% |
| Atrial Fibrillation |
3.8% |
| Pulmonary Embolism |
3.8% |
| Sepsis |
3.5% |
| Diarrhoea |
3.4% |
| Urinary Tract Infection |
3.4% |
| Dyspnoea |
3.3% |
| Nausea |
3.3% |
| Cardiac Failure |
3.3% |
|
| Interacting |
| Hypertension |
18.9% |
| Myocardial Infarction |
17.9% |
| Product Used For Unknown Indication |
12.6% |
| Atrial Fibrillation |
12.0% |
| Dementia |
7.3% |
| Tuberculosis Bladder |
6.6% |
| Drug Use For Unknown Indication |
4.7% |
| Type 2 Diabetes Mellitus |
3.0% |
| Trigeminal Neuralgia |
2.3% |
| Onychomycosis |
2.0% |
| Amnesia |
1.3% |
| Arrhythmia |
1.3% |
| Cardiac Failure |
1.3% |
| Essential Hypertension |
1.3% |
| Memory Impairment |
1.3% |
| Pain |
1.3% |
| Prostate Cancer |
1.3% |
| Renal Failure Chronic |
1.3% |
| Abnormal Behaviour |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
|
| Drug Interaction |
32.9% |
| Sinus Bradycardia |
9.2% |
| Myocardial Infarction |
5.3% |
| Palpitations |
5.3% |
| Renal Failure |
5.3% |
| Hypertension |
3.9% |
| Hypoglycaemia |
3.9% |
| Hypotension |
3.9% |
| Myalgia |
3.9% |
| Rhabdomyolysis |
3.9% |
| Blood Creatinine Increased |
2.6% |
| Blood Pressure Increased |
2.6% |
| Drug Ineffective |
2.6% |
| Dysarthria |
2.6% |
| Dysphonia |
2.6% |
| Presyncope |
2.6% |
| Ventricular Extrasystoles |
2.6% |
| Atrial Fibrillation |
1.3% |
| Cerebral Infarction |
1.3% |
| Circulatory Collapse |
1.3% |
|
